135 related articles for article (PubMed ID: 8659456)
1. Lupus anticoagulants: first French interlaboratory Etalonorme survey.
Roussi J; Roisin JP; Goguel A
Am J Clin Pathol; 1996 Jun; 105(6):788-93. PubMed ID: 8659456
[TBL] [Abstract][Full Text] [Related]
2. The Lupus Ratio test--an interlaboratory study on the detection of Lupus anticoagulants by an APTT-based, integrated, and semi-quantitative test. Fifth International Survey of Lupus Anticoagulants--ISLA 5.
Jacobsen EM; Barna-Cler L; Taylor JM; Triplett DA; Wisløff F
Thromb Haemost; 2000 May; 83(5):704-8. PubMed ID: 10823266
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity of sixteen APTT reagents for the presence of lupus anticoagulants.
Denis-Magdelaine A; Flahault A; Verdy E
Haemostasis; 1995; 25(3):98-105. PubMed ID: 7607585
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of lupus anticoagulant in women with spontaneous abortion in Zaria.
Ibrahim IN; Mamman AI; Adaji SE; Hassan A; Babadoko AA
Niger J Clin Pract; 2017 Sep; 20(9):1145-1149. PubMed ID: 29072238
[TBL] [Abstract][Full Text] [Related]
5. Laboratory diagnosis of lupus anticoagulants for patients on oral anticoagulant treatment. Performance of dilute Russell viper venom test and silica clotting time in comparison with Staclot LA.
Tripodi A; Chantarangkul V; Clerici M; Mannucci PM
Thromb Haemost; 2002 Oct; 88(4):583-6. PubMed ID: 12362227
[TBL] [Abstract][Full Text] [Related]
6. Recommendations for appropriate activated partial thromboplastin time reagent selection and utilization.
Fritsma GA; Dembitzer FR; Randhawa A; Marques MB; Van Cott EM; Adcock-Funk D; Peerschke EI
Am J Clin Pathol; 2012 Jun; 137(6):904-8. PubMed ID: 22586049
[TBL] [Abstract][Full Text] [Related]
7. A rapid screen for lupus anticoagulant with good discrimination from oral anticoagulants, congenital factor deficiency and heparin, is provided by comparing a sensitive and an insensitive APTT reagent.
Brancaccio V; Ames PR; Glynn J; Iannaccone L; Mackie IJ
Blood Coagul Fibrinolysis; 1997 Apr; 8(3):155-60. PubMed ID: 9167015
[TBL] [Abstract][Full Text] [Related]
8. Potentially clinically important inaccuracies in testing for the lupus anticoagulant: an analysis of results from three surveys of the UK National External Quality Assessment Scheme (NEQAS) for Blood Coagulation.
Jennings I; Kitchen S; Woods TA; Preston FE; Greaves M
Thromb Haemost; 1997 May; 77(5):934-7. PubMed ID: 9184405
[TBL] [Abstract][Full Text] [Related]
9. Laboratory identification of lupus anticoagulants: results of the Second International Workshop for Identification of Lupus Anticoagulants. On behalf of the Subcommittee on Lupus Anticoagulants/Antiphospholipid Antibodies of the ISTH.
Brandt JT; Barna LK; Triplett DA
Thromb Haemost; 1995 Dec; 74(6):1597-603. PubMed ID: 8772243
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a new silica clotting time in the diagnosis of lupus anticoagulants.
Devreese KM
Thromb Res; 2007; 120(3):427-38. PubMed ID: 17156825
[TBL] [Abstract][Full Text] [Related]
11. Lupus anticoagulant testing in Europe: an analysis of results from the first European Concerted Action on Thrombophilia (ECAT) survey using plasmas spiked with monoclonal antibodies against human beta2-glycoprotein I.
Arnout J; Meijer P; Vermylen J
Thromb Haemost; 1999 Jun; 81(6):929-34. PubMed ID: 10404770
[TBL] [Abstract][Full Text] [Related]
12. Interpretation of normal plasma mixing studies in the laboratory diagnosis of lupus anticoagulants.
Devreese KM
Thromb Res; 2007; 119(3):369-76. PubMed ID: 16704874
[TBL] [Abstract][Full Text] [Related]
13. How to Optimize Activated Partial Thromboplastin Time (APTT) Testing: Solutions to Establishing and Verifying Normal Reference Intervals and Assessing APTT Reagents for Sensitivity to Heparin, Lupus Anticoagulant, and Clotting Factors.
Favaloro EJ; Kershaw G; Mohammed S; Lippi G
Semin Thromb Hemost; 2019 Feb; 45(1):22-35. PubMed ID: 30630206
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of sensitivity and specificity of confirmatory assays for lupus anticoagulant (LA) detection].
Imoto K; Yasumuro Y; Taki M; Suzuki Y; Akatu S; Tajima C; Ichikawa Y
Rinsho Byori; 1996 Aug; 44(8):797-801. PubMed ID: 8816068
[TBL] [Abstract][Full Text] [Related]
15. Two different incubation times for the activated partial thromboplastin time (APTT): a new criterion for diagnosis of lupus anticoagulant.
Robert A
Thromb Haemost; 1994 Feb; 71(2):220-4. PubMed ID: 8191402
[TBL] [Abstract][Full Text] [Related]
16. The evaluation of clotting times in the laboratory detection of lupus anticoagulants.
Jacobsen EM; Barna-Cler L; Taylor JM; Triplett DA; Wisløff F
Thromb Res; 2001 Nov; 104(4):275-82. PubMed ID: 11728529
[TBL] [Abstract][Full Text] [Related]
17. Effects of direct oral anticoagulants on lupus anticoagulant assays in a real-life setting.
Antovic A; Norberg EM; Berndtsson M; Rasmuson A; Malmström RE; Skeppholm M; Antovic J
Thromb Haemost; 2017 Aug; 117(9):1700-1704. PubMed ID: 28640321
[TBL] [Abstract][Full Text] [Related]
18. Comparison of test methods for the lupus anticoagulant: international survey on lupus anticoagulants-I (ISLA-1).
Exner T; Triplett DA; Taberner DA; Howard MA; Harris EN
Thromb Haemost; 1990 Nov; 64(3):478-84. PubMed ID: 2128977
[TBL] [Abstract][Full Text] [Related]
19. Comparison of six dilute russell viper venom time lupus anticoagulant screen/confirm assay kits.
McGlasson DL; Fritsma GA
Semin Thromb Hemost; 2013 Apr; 39(3):315-9. PubMed ID: 23468380
[TBL] [Abstract][Full Text] [Related]
20. [Interference of factor VIII excess on the detection of lupus anticoagulants by the activated partial thromboplastin time].
Guermazi S; Gorgi Y; Ayed K; Dellagi K
Pathol Biol (Paris); 1997 Jan; 45(1):28-33. PubMed ID: 9097843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
